744 



GENERAL INDEX 



Epinephrin, pharmacodynamic action 



of, on voluntary muscle, i, 127. 

 seat of, i, 124. 



pressor effect of, ii, 191. 



factors modifying, ii, 230. 



quantitative output of, ii, 131. 



action on, of drugs, ii, 146. 



atropin, ii, 149. 



curare, ii, 149. 



nicotin, ii, 147, 148. 



physostigmin, ii, 151. 



pilocarpin, ii, 149. 



strychnin, ii, 146, 149. 



control of, by nervous system, ii, 



134. 



abdominal sympathetic, ii, 136. 



afferent paths, ii, 140. 



central nervOus mechanism, ii, 



137. 



sensory nerves, ii, 140. 



splanchnic nerve, ii, 134. 

 for cats (29), under urethane, ii, 



132. 

 for dogs (17), under morphin and 



ether, ii, 133. 



for macaque monkeys (2), ii, 134. 



influence on, of asphyxia, ii, 143. 



respiratory effects of, ii, 243. 



response to, of alimentary canal, ii, 

 238. 



of bladder, ii, 239. 



of body temperature, ii, 249. 



of bronchioles, ii, 241. 



of genital organs, ii, 240. 

 of glands, ii, 243. 



of kidney activity, ii, 244. 



of metabolism, general, ii, 246. 

 sugar, ii, 246. 



of muscular activity, ii, 250. 



of pigment cells, ii, 242. 



of the pupils, ii, 237. 



of respiratory system, ii, 243. 



of smooth muscle in skin, ii, 242. 

 of sweat glands, ii, 242. 



of ureter, ii, 239. 



of urethra, ii, 239. 



store of, in suprarenals, ii, 164. 



symptomatic etherapy of, i, 134. 

 vasoconstricting action, i, 134. 



terminology of, ii, 92. 



use of, in therapy, ii, 943. 



vasoconstricting action of, i, 134. 

 in alimentary canal, i, 136. 



-in eye, i, 136. 



in genito-urinary tract, i, 136. 



in hemorrhage, accessible, i, 135. 



inaccessible, i, 137, 138. 



in local anesthesia, i, 135. 



Epinephrin, vasoconstricting action of, 

 in mouth and upper air passages, i, 

 135. 



in skin affections, i, 138. 



remote or systemic, i, 137. 



vasoconstrictor effect of, ii, 191. 



problem of, ii, 189. 



vasodilator effects of, Cannon and 

 Lyman (1913), ii, 199. 



characteristic of vasomotor reac- 

 tion to epinephrin, ii, 203. 



-Dale (1906), ii, 198. 

 -Elliott (1905), ii, 198. 

 -Hartman (1915), ii, 200. 

 -Hoskins and McClure (1912), ii, 

 199. 



indications from observations, ii, 

 201. 



-Meltzer, S. J. and Clara (1903), 

 ii, 198. 



-Moore and Purinton (1900), ii, 

 197. 



nervous mechanism involved in, 

 ii, 201. 



-location of, 202. 



in various orders of vertebrates, 



ii, 203. 



"vasodilator mechanism" of, ii, 203. 



vasomotor reaction to, ii, 203. 

 Epinephrin content, in Addison's dis- 

 ease, ii, 282. 



in infectious diseases, ii, 321. 

 Epinephrinemia, due to drugs, iii, 782. 

 Epinephrin enemata, i, 136. 



in tetany, i, 610. 



Epinephrin hypersensitiveness test 

 (Goetsch) for hyperthyroidism, i, 172. 



evolvement of, i, 477. 



function of thyroid secretion 



forming basis for, i, 475. 



in adenoma cases, i, 481. 



in colloid goiter, i, 480. 



in exophthalmic goiter cases, i, 



480. 

 in hypothyroidism, i, 481. 



procedure, i, 478. 

 reaction to, i, 477, 479. 



signs and symptoms necessary 



for interpretation of test as positive, 

 i, 480. 



summary of results of, i, 483. 



value of, in differential diagnosis 



of many conditions simulating hy- 

 perthyroidism, i, 482. 



in estimating degree of tox- 

 icity present in early exophthalmic 

 goiter, i, 482. 



over other tests, i, 483. 



